New
Horizon Pharma
The AI engine Fit Assessment
BetaThe company demonstrates pharmaceutical technology activity through patenting and development related to gout treatment (reducing immunogenicity to pegloticase). Check Source
Blurb
Horizon Therapeutics focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.
HQ Location
Northbrook (United States)
Founded
2005
Employees
1001 - 5000
Total funding raised
$32.43B
Funding Status
Acquired by Amgen, December 2022
Developer of drug therapies intended to deliver medicines for rare, autoimmune, and severe inflammatory diseases. The company is focused on discovering, developing, and commercializing medicines to address the needs of people impacted by rare, autoimmune, and severe inflammatory diseases, enabling medical staff to supply critical medicine for treating autoimmune diseases.